VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Director Buying

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Apr 22, 2024 10:43pm

95 Views

Post# 36002568

RE:Director Buying

Pandora wrote:
If the directors are buying right now does that mean we cannot expect news for a particular timeframe?

Just a simple question on trading rules and you come out with some page filling convoluted response without an answer to the question.

Funny you didn't manage to throw the word 'Fudster" in there -- that's got to be a positive.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant